Antiproliferative effects induced by guanine-based purines require hypoxanthine-guanine phosphoribosyltransferase activity

Biological Chemistry - Tập 391 Số 9 - 2010
Rosaria Garozzo1, Maria Angela Sortino2, Carlo Vancheri3, D. F. Condorelli1
1Department of Chemical Sciences, Section of Biochemistry, University of Catania, I-95125 Catania, Italy
2Departments of Experimental and Clinical Pharmacology, University of Catania, I-95125 Catania, Italy
3Department of Internal Medicine, University of Catania, I-95100, Catania, Italy

Tóm tắt

Abstract Guanine (GUA), guanosine and GMP exert a marked growth inhibition on the U87 glioma cell line that is not seen with other tested nucleotides, nucleosides and nucleobases. This effect could be replicated in several different human tumoral cell lines. Guanine shows a higher potency than guanosine or GMP, and co-treatments with adenosine or adenine are able to antagonize or revert the antiproliferative effect of guanine. The loss of the guanine effect in a cell line bearing a mutated inactive hypoxanthine-guanine phosphoribosyltransferase (HGPRT), and the decreased potency of GUA in U87 cells silenced for HGPRT transcripts, demonstrates the central role of the intracellular metabolism of GUA for growth-inhibitory effects. Considering the potential application of growth-inhibitory substances in anticancer therapy, knowledge of the molecular mechanism underlying GUA-induced effects encourages studies aimed at defining possible tumoral targets for experimental therapies.

Từ khóa


Tài liệu tham khảo

Batiuk T.D., 2001, Am. J. Physiol. Cell. Physiol., 281, C1776, 10.1152/ajpcell.2001.281.6.C1776

10.1007/0-306-46812-3_12

10.1002/(SICI)1098-1136(19990101)25:1<93::AID-GLIA9>3.0.CO;2-N

10.1002/(SICI)1098-1136(20000201)29:3<202::AID-GLIA2>3.0.CO;2-C

10.1016/S0736-5748(00)00084-8

10.1002/glia.440070207

10.1002/ddr.1128

10.1002/glia.20002

10.1038/35078107

10.1016/S0006-8993(03)02506-X

10.1097/00001756-199211000-00013

10.1016/0736-5748(95)00083-6

10.1111/j.1471-4159.1987.tb03419.x

10.1002/jnr.490280318

Kim S.G., 1997, J. Pharm. Pharmacol., 49, 216, 10.1111/j.2042-7158.1997.tb06783.x

10.1096/fj.06-5730rev

10.1016/0006-8993(95)00156-K

Moosavi M.A., 2006, J. Biochem. Mol. Biol., 39, 492

10.1038/sj.leu.2401890

10.1023/A:1025699932270

10.1016/0022-1759(83)90303-4

Osti F., 1997, Haematologica, 82, 395

Park T.S., 1987, Cereb. Blood Flow Metab., 7, 178, 10.1038/jcbfm.1987.41

10.1097/00001756-199111000-00007

Rathbone M.P., 1992, Cell. Dev. Biol., 28, 529, 10.1007/BF02634137

Rathbone M.P., 2008, Nucleos. Nucleot. Nucl., 28, 666, 10.1080/15257770802143913

Ritzel M.W., 1997, Physiol., 27, C707

10.1038/sj.bjp.0704542

Van Wylen D.G., 1986, J. Cereb. Blood Flow Metab., 6, 522, 10.1038/jcbfm.1986.97

10.1016/0304-3940(82)90338-X

Thông tin
Thông tin xuất bản

Biological Chemistry

Tập 391 Số 9

Thông tin tác giả